title: Clostridium difficile infection is a risk factor for bacteremia due to vancomycin-resistant enterococci (VRE) in VRE-colonized patients with acute leukemia.
abstract: A cohort study was conducted in a cancer center to identify risk factors for bacteremia with vancomycin-resistant enterococci (VRE) in neutropenic cancer patients colonized with VRE. There were 10 patients with VRE bacteremia among 56 colonized with VRE, of whose charts 51 were available for review. One hundred percent of patients with VRE bacteremia (10 of 10) vs. 56% of patients without VRE bacteremia (23 of 41) had acute leukemia (P = .01, Fisher's exact test). Four of the 10 patients with VRE bacteremia had a positive Clostridium difficile toxin assay within 6 days of their first positive VRE blood culture. Both C. difficile infection and antimicrobial (vancomycin and ciprofloxacin) use during VRE colonization were significant risk factors for VRE bacteremia in univariate analysis. When a Cox proportional hazards model was used to account for differences in follow-up time, C. difficile infection was the only statistically significant risk factor (risk ratio, 8.2; P = .007) for VRE bacteremia in VRE-colonized patients with acute leukemia.
authors.affiliation: Department of Medicine, University of Maryland School of Medicine and Veterans Affairs Maryland Health Care System, Baltimore 21201, USA.
authors.forename: M C
authors.initials: MC
authors.lastname: Roghmann
authors.forename: R J
authors.initials: RJ
authors.lastname: McCarter
authors.forename: J
authors.initials: J
authors.lastname: Brewrink
authors.forename: A S
authors.initials: AS
authors.lastname: Cross
authors.forename: J G
authors.initials: JG
authors.lastname: Morris
mesh_terms: D000208:Acute Disease; D016470:Bacteremia / Q000150:complications / Q000382:microbiology*; D016360:Clostridioides difficile / Q000187:drug effects* / Q000302:isolation & purification; D015331:Cohort Studies; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects / Q000302:isolation & purification; D004761:Enterocolitis, Pseudomembranous / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D005260:Female; D005500:Follow-Up Studies; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000382:microbiology*; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000150:complications; D012307:Risk Factors; D014640:Vancomycin / Q000494:pharmacology*
chemical_list: D014640:Vancomycin